Gliogen-250Mg Capsule belongs to a class of medicines called 'anti-cancer/ antitumor agent', used to treat specific forms of brain tumours such as glioblastoma multiforme (a type of tumour that grows and spreads rapidly) in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma (a rare malignant brain tumour) in patients older than 3years. A brain tumour is an uncontrolled and unregulated proliferation of cells in the brain. 

Gliogen-250Mg Capsule contains Temozolomide which works by inhibiting the production of DNA (deoxyribonucleic acid-genetic material of the cell), thereby affecting cell growth and division. Thus, Gliogen-250Mg Capsule prevents tumours from growing.

Take Gliogen-250Mg Capsule as prescribed. In some cases, Gliogen-250Mg Capsule may cause loss of appetite, anxiety, confusion, headache, vomiting, nausea, diarrhoea, constipation, muscle weakness, muscle aches, and fever. Most of these side effects of Gliogen-250Mg Capsule do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Let your doctor know if you are allergic to any of the contents. Gliogen-250Mg Capsule is not recommended for patients with severe bone marrow depression or significant bleeding. Avoid taking Gliogen-250Mg Capsule if you are pregnant or breastfeeding. Both women and men using Gliogen-250Mg Capsule should use birth control to avoid pregnancy and fathering a child. It would be best not to drive and/or operate machines that require alertness as Gliogen-250Mg Capsule may cause tiredness or sleepiness.

Gliogen-250Mg Capsule belongs to a class of medicines called anti-cancer/antitumor agents used to treat specific forms of brain tumours such as glioblastoma multiforme (a type of tumour that grows and spreads rapidly) in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma (a rare malignant brain tumour) in patients older than 3years. It contains Temozolomide which works by binding to the DNA (deoxyribonucleic acid-genetic material of the cell) and interfering with cell growth and division. Thus, Gliogen-250Mg Capsule prevents tumours from growing.

Gliogen-250Mg Capsule should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Gliogen-250Mg Capsule. To treat your condition effectually, continue taking Gliogen-250Mg Capsule for as long as your doctor has prescribed. Do not stop Gliogen-250Mg Capsule midway under any circumstances without consulting the healthcare professional. Inform your doctor if you have an allergy to any components of Gliogen-250Mg Capsule. Inform your doctor before taking Gliogen-250Mg Capsule if you have allergic reactions, infections, lung, renal or hepatic disorders or low blood count (including neutropenia, lymphopenia, thrombocytopenia). Gliogen-250Mg Capsule is not recommended for patients with severe bone marrow depression or significant bleeding. Avoid taking Gliogen-250Mg Capsule if you are pregnant or breastfeeding. Both women and men using Gliogen-250Mg Capsule should use birth control to avoid pregnancy or fathering a child. Do not receive any vaccinations or immunizations without your doctor's approval while taking Gliogen-250Mg Capsule.